Advancements in modern medicine over the past century have been directly responsible for raising the average human’s lifespan some 40 years. Although researchers and practitioners have made great strides in the world of medicine, something they do on a day-to-day basis, we haven’t got too far into the world of biotechnology yet.
According to Carsten Thiel, the Golden Age of Biotechnology is right in front of society. We’re effectively running into the soon-to-come era at full speed.
Carsten Thiel has a Ph.D and was the CEO of Abeona Therapeutics Inc. This is a biopharmaceutical company for clinical-stages that mainly develops gene and cell therapies for genetic diseases that are rare and life-threatening.
Biotechnology expert Carsten Thiel believes that the Golden Age of Biotechnology will help solve diseases that we don’t have great cures for, prevent them, and otherwise keep people healthier than they are right now.
Carsten believes that there are three primary drivers behind the many recent advancements in biotechnology.
The Human Genome Project initially took a whopping 13 years to sequence the human genome. Today, a human’s genome can be sequenced in no longer than two days. Further, it only costs a few hundred dollars. The cost of the Human Genome Project’s first sequencing was roughly $1 billion. See Related Link for more information.
Faster and cheaper biotech-related processes are helping us edge into the “Golden Age of Biotechnology”.
The second driver is that researchers and practitioners of medicine have access to more tools than ever before. For example, we now have antibody therapies available for widespread use.
Carsten Thiel’s third driver is that we understand the biology of our bodies better than ever before. Our advances in the world of cellular biology have been particularly important.